Related Experiment Video
Updated: Jun 19, 2026
Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
Published on: November 11, 2021
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
1Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD 57007, USA.
Abstract:
Our previous studies illustrated that berberine inhibited adipogenesis in murine-derived 3T3-L1 preadipocytes and human white preadipocytes. In this study, the effects of berberine on the adipogenesis of high-fat diet-induced obesity (FD) or normal diet (ND) mice and possible transcriptional impact are investigated. The results demonstrated that in FD mice, berberine reduced mouse weight gain and food intake and serum glucose, triglyceride, and total cholesterol levels accompanied with a down-regulation of PPARgamma expression and an up-regulation of GATA-3 expression. Berberine had no adverse effects on ND mice. These encouraging findings suggest that berberine has excellent pharmacological potential to prevent obesity.
Insights
Berberine effectively combats obesity by reducing weight gain and improving metabolic markers in mice on a high-fat diet. This natural compound shows promise for preventing obesity and related health issues.
Area of Science:
- Biochemistry
- Metabolic research
- Pharmacology
Background:
- Previous studies indicated berberine inhibits adipogenesis in cell cultures.
- Obesity is a growing global health concern with complex metabolic underpinnings.
Purpose of the Study:
- To investigate berberine's effects on diet-induced obesity in mice.
- To explore the transcriptional changes associated with berberine treatment.
Main Methods:
- Administered berberine to mice fed a high-fat diet (FD) or normal diet (ND).
- Monitored weight gain, food intake, and serum biochemical parameters.
- Analyzed the expression of key adipogenic transcription factors, PPARgamma and GATA-3.
Main Results:
- Berberine significantly reduced weight gain, food intake, and improved serum glucose, triglyceride, and cholesterol levels in FD mice.
- Observed down-regulation of PPARgamma and up-regulation of GATA-3 expression in FD mice treated with berberine.
- No adverse effects were noted in ND mice.
Conclusions:
- Berberine demonstrates significant anti-obesity effects in a high-fat diet mouse model.
- The compound modulates key transcriptional pathways involved in adipogenesis.
- Berberine presents a promising pharmacological potential for obesity prevention.
